Sign up for free insights newsletter
GX

Gerresheimer AG

GXIXETRA (Frankfurt)

Need professional-grade analysis? Visit stockanalysis.com

€22.04
+3.38%
End of day
Market Cap

$736.39M

P/E Ratio

31.35

Employees

13,535

Dividend Yield

0.19%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino0.61-0.61-0.71-1.04-0.69-0.64
Calmar1.22-1.15-0.90-0.78-0.28-0.52
Sharpe0.26-0.44-0.51-0.83-0.52-0.51
Omega1.180.980.940.820.930.94
Martin1.95-1.81-1.79-1.21-0.62-0.94
Ulcer0.0011.8426.8723.5448.7539.1731.90

Gerresheimer AG (GXI) Price Performance

Gerresheimer AG (GXI) trades on XETRA (Frankfurt) in EUR. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at EUR22.04, up 3.38% from the previous close.

Over the past year, GXI has traded between a low of EUR15.70 and a high of EUR64.00. The stock has lost 58.7% over this period. It is currently 65.6% below its 52-week high.

Gerresheimer AG has a market capitalization of $736.39M, with a price-to-earnings ratio of 31.35 and a dividend yield of 0.19%.

About Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery devices, including inhalers, injection/auto injectors, and pen injectors. The company also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, it offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. The company offers its products to pharmacy chains, supermarkets, and wholesalers. It serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.

Compare Gerresheimer AG

Side-by-side comparison against top Healthcare peers.

Company Info

Exchange
XETRA (Frankfurt)
Currency
EUR
Country
Germany

Financial Metrics

Revenue (TTM)
$2.25B
EBITDA
$384.99M
Profit Margin
1.04%
EPS (TTM)
0.68
Book Value
40.59

Technical Indicators

52 Week High
€66.45
52 Week Low
€14.83
50 Day MA
€19.15
200 Day MA
€29.95
Beta
0.33

Valuation

Trailing P/E
31.35
Forward P/E
7.43
Price/Sales
0.33
Price/Book
0.53
Enterprise Value
$2.72B